Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Pharmacoepidemiology and Drug Safety|December 3, 2016
Octreotide use and safety in infants with hyperinsulinismAnn W McMahon, Gerold T Wharton, Paul Thornton, et al.
Pediatrics|October 26, 2011
Age and risks of FDA-approved long-acting β₂-adrenergic receptor agonistsAnn W McMahon, Mark S Levenson, Bradley W McEvoy, et al.
Therapeutic Innovation & Regulatory Science|October 25, 2016
Stratification, Hypothesis Testing, and Clinical Trial Simulation in Pediatric Drug DevelopmentAnn W McMahon, Kevin Watt, Jian Wang, et al.
Pharmacoepidemiology and Drug Safety|December 22, 2015
Pediatric registries at the Food and Drug Administration: design aspects that increase their likelihood of successScott K Winiecki, M Isabel Tejero-Taldo, Debbie Avant, et al.
Pediatrics|June 20, 2012
Trends of outpatient prescription drug utilization in US children, 2002-2010Grace Chai, Laura Governale, Ann W McMahon, et al.
Journal of Clinical Pharmacology|June 29, 2021
Drug Safety in Labeling for Pediatric Drug Development and Dose Selection in Submissions to the US Food and Drug AdministrationClara Kim, Kyunghun Park, Ann W McMahon, et al.
JAMA Pediatrics|November 20, 2018
Duration of Pediatric Clinical Trials Submitted to the US Food and Drug AdministrationKanecia O Zimmerman, P Brian Smith, Ann W McMahon, et al.
Pageof 3